A 2026 structured overview of VidaCalm's 18-ingredient hearing support formula, ingredient research context, safety considerations, and what consumers searching for...
GUANGZHOU, China , April 17, 2026 /PRNewswire/ -- From March 28 to 30, 2026, the 4th International Conference on Single-Cell and...
Live event to be held on Thursday, April 23, at 2:00 p.m. ET Company focused on advancing launch strategy ahead...
The Cala kIQ Plus provides new therapy modes and adaptive calibration designed to optimize tremor relief and personalize treatment Data to...
Findings may improve understanding of how smells are processed and speed up computing by artificial intelligence toolsNEW YORK, April 14,...
FDA assigned PDUFA target action date of January 29, 2027 No advisory committee meeting expected BOSTON, April 14, 2026 (GLOBE...
Findings underpin the scientific rationale for Anavex’s targeted autophagy approach with orally administered blarcamesine Convergence of impaired autophagy and synaptic...
Cambridge, Massachusetts--(Newsfile Corp. - April 13, 2026) - ProMIS Neurosciences, Inc. (NASDAQ: PMN), a clinical-stage biotechnology company developing next-generation therapies...
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing SymposiumMONTREAL and CHARLOTTE, N.C., April 10, 2026...
Siemens Healthineers joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementiasWASHINGTON, April 09,...
Clinical studies link modern stress to measurable changes in brain architecture, fueling a new movement toward "brain fitness."NEW BERN, N.C.,...
As brain–computer interfaces advance, neural data emerges as a key asset.NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience...
As brain–computer interfaces advance, neural data emerges as a key asset.NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience...
Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal...
Dr. Dunia Korous, a highly credentialed dentist specializing in TMJ therapy and airway-focused dentistry, announces the launch of a new website...
Innovative Program Expands Access to Immersive Healthcare to Help Veterans Fight Chronic Pain, Anxiety, Stress, and Isolation While Advancing At-Home...
ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...
BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a...
PDUFA target action date of November 14, 2026 Potential first FDA-approved treatment option for the acute treatment of agitation associated...
Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitor Acquisition further expands Axsome’s industry-leading CNS...